Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$0.0 - $9.95 $0 - $13,233
1,330 Added 0.66%
203,578 $0
Q3 2022

Nov 14, 2022

BUY
$8.57 - $11.57 $690,999 - $932,889
80,630 Added 66.3%
202,248 $1.8 Million
Q2 2022

Aug 12, 2022

BUY
$8.84 - $11.64 $55,709 - $73,355
6,302 Added 5.46%
121,618 $1.21 Million
Q1 2022

May 13, 2022

BUY
$10.07 - $11.93 $1.16 Million - $1.38 Million
115,316 New
115,316 $1.34 Million

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Parkman Healthcare Partners LLC Portfolio

Follow Parkman Healthcare Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.